Imaging of non–small-cell lung cancer with indium-111 pentetreotide

SK Lau, DS Johnson, MN Coel - Clinical nuclear medicine, 2000 - journals.lww.com
Purpose Lung cancer is the leading cause of cancer deaths in the United States. Non–small-
cell lung cancer (NSCLC) accounts for 75% to 85% of lung cancers. CT has been the …
被引用次数：14 相关文章

Imaging of non-small-cell lung cancer with indium-111 pentetreotide.

SK Lau, DS Johnson, MN Coel - Clinical Nuclear Medicine, 2000 - europepmc.org
Purpose Lung cancer is the leading cause of cancer deaths in the United States. Non-small-
cell lung cancer (NSCLC) accounts for 75% to 85% of lung cancers. CT has been the …

Imaging of Non–Small-Cell Lung Cancer With Indium-111 Pentetreotide

SK LAU, DS JOHNSON, MN COEL - Clinical Nuclear Medicine, 2000 - journals.lww.com
Purpose Lung cancer is the leading cause of cancer deaths in the United States. Non–small-
cell lung cancer (NSCLC) accounts for 75% to 85% of lung cancers. CT has been the …

[引用][C] Imaging of non-small-cell Lung cancer with indium-111 pentetreotide

SK LAU, DS JOHNSON, MN COEL - Clinical nuclear medicine, 2000 - pascal-francis.inist.fr
Imaging of non-small-cell Lung cancer with indium-111 pentetreotide CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Imaging of non-small-cell lung cancer with indium-111 pentetreotide

SK Lau, DS Johnson, MN Coel - Clinical nuclear …, 2000 - pubmed.ncbi.nlm.nih.gov
Purpose Lung cancer is the leading cause of cancer deaths in the United States. Non-small-
cell lung cancer (NSCLC) accounts for 75% to 85% of lung cancers. CT has been the …

[引用][C] Imaging of non-small-cell Lung cancer with indium-111 pentetreotide

SK LAU, DS JOHNSON, MN COEL - Clinical nuclear medicine, 2000 - Lippincott